The researchers sought to understand the prognostic value of tau positron emission tomography for predicting cognitive decline across the clinical spectrum of Alzheimer disease.
A cognitively active lifestyle in old age may delay the onset of dementia in Alzheimer disease (AD) by as much as five years.
Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer disease drug with a high price tag and unproven benefits that have prompted widespread controversy.
Timely anticipatory planning in early dementia is crucial to preserve autonomy over future decisions and to reduce caregiver strain
The researchers conducted a randomized, placebo-controlled, multi-arm trial of gantenerumab or solanezumab in participants with dominantly inherited Alzheimer disease across asymptomatic and symptomatic disease stages.
The treatment, which is administered as a monthly intravenous infusion, binds to aggregated β-amyloid and promotes removal of amyloid from the brain.
The U.S. Food and Drug Administration on Thursday issued new prescribing rules for the controversial Alzheimer disease medication Aduhelm that will likely limit its use.
Tooth loss is independently associated with a higher risk for cognitive impairment and dementia.
Study researchers sought to differentiate between HIV-associated neurocognitive disorder and true Alzheimer disease in patients with HIV.
The researchers hypothesized that as the participants became older adults, their cognitive functioning would decline more steeply relative to earlier assessments.